Global HPV testing and Pap test Market Size, Status and Forecast 2024, Our objective is to provide strategic key market information like Sales Volume, Market Share, market size estimations, CAGR, Competition by Players/Suppliers, 5-year market forecast & Industry trends etc.
The target geography in this research report is USA, Europe, Asia-Pacific, Middle East and Africa.
Several factors such as increasing number of cervical cancer cases, growing aging population, increasing awareness of cervical cancer screening programs, and government initiative and funding are propelling the growth of the HPV testing and Pap test market.
This research report segments the HPV Testing & Pap Test Market based on by test type, application, end user, and region.
An increasing number of cervical cancer cases and a growing aging population
Cervical cancer is the fourth most prevalent forms of cancer globally and is the most common cause of death among women (Source: Global Cancer Facts and figures). It has been estimated that 527,624 new cases of cervical cancer have emerged worldwide, while 265,653 women died due to cervical cancer in 2012. This figure is expected to reach to 609,270 new cases and 315,727 deaths by 2020.
Approximately 26,000 new cancers attributable to HPV occur each year, 18,000 among females and 8,000 among males (Source: CDC). The growing number of cervical cancer cases results in the need for new, technically advanced, and less expensive screening programs. This, in turn, is expected to drive the HPV testing and Pap test market in the coming years.
Request Research Sample Pages:
HPV Testing & Pap Test Market Based on Application;
Based on the application, the Pap test market is segmented into cervical cancer screening and vaginal cancer screening. The cervical cancer screening segment is expected to grow at the highest CAGR during the forecast period, owing to the growing incidences of cervical cancer.
Global HPV testing and Pap test Market, by Region
HPV Testing & Pap Test Market Based on end user;
On the basis of end user, the HPV testing and Pap test market is categorized into hospitals, laboratories, physician’s offices and clinics. The hospitals segment is projected to grow at the highest CAGR. This growth is attributed to the increasing patient volumes in hospitals, as most diagnostic tests are carried out in-house with advanced technologies and more accessibility.
HPV Testing & Pap Test Market’s Major Key Players:
Key players in the HPV testing and Pap test market include Hologic Inc. (U.S.), Qiagen N.V. (Netherlands), F. Hoffmann-La Roche Ltd. (Switzerland), Quest Diagnostics (U.S.), OncoHealth Corporation (U.S.), and Becton, Dickinson and Company (U.S.).
We just sent you an email. Please click the link in the email to confirm your subscription!
OKSubscriptions powered by Strikingly